Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

36
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36
Translation01:31

Translation

16.0K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.0K
Ribosome Profiling02:24

Ribosome Profiling

3.7K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.7K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same author

Congenital myopathies in adult patients: lived experiences and coping mechanisms.

Disability and rehabilitation·2026
Same author

Evaluation of Dysphagia in Myositis and Muscular Dystrophy Using Real-Time MRI and Quantitative Muscle Ultrasound.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Brain Age in Conduct Disorder:: A Mega-Analysis of the ENIGMA Antisocial Behavior Working Group.

bioRxiv : the preprint server for biology·2026
Same author

Different operationalizations of the capability approach in evaluating rehabilitation for persons with neuromuscular diseases: a mixed-methods study.

Disability and rehabilitation·2025
Same author

Immunohistological and electron microscopy profile of unique TIRM-MRI guided muscle biopsies of FSHD patients.

Journal of neuromuscular diseases·2025

Related Experiment Video

Updated: Sep 29, 2025

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.1K

Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).

Sylvia Nieuwenhuis1,2, Joanna Widomska2, Paul Blom3

  • 1Center for Molecular and Biomolecular Informatics (CMBI), Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands.

International Journal of Molecular Sciences
|March 25, 2022
PubMed
Summary

Blood transcriptome analysis in type I myotonic dystrophy (DM1) reveals that disease severity correlates with changes in immune system gene expression. These findings highlight the role of immunity in DM1 progression.

Keywords:
DM1 disease severityRNA sequencingbloodimmunitymuscle impairment rating scale (MIRS)myotonic dystrophy type 1 (DM1)pathway analysis

More Related Videos

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.6K
Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches
08:33

Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches

Published on: October 17, 2019

12.3K

Related Experiment Videos

Last Updated: Sep 29, 2025

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.1K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.6K
Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches
08:33

Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches

Published on: October 17, 2019

12.3K

Area of Science:

  • Genomics
  • Immunology
  • Neurology

Background:

  • Type I myotonic dystrophy (DM1) is a progressive multisystem disorder.
  • Understanding the molecular basis of DM1 disease severity is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the association between blood transcriptome alterations and disease severity in DM1 patients.
  • To validate observed transcriptomic changes in an independent DM1 dataset.
  • To identify biological pathways linked to DM1 progression.

Main Methods:

  • Analysis of blood transcriptome data from the OPTIMISTIC study and the DMBDI dataset.
  • Correlation of gene expression with disease severity (MIRS) and DMPK repeat length.
  • Utilized pathway analysis, gene ontology, and upstream regulator analyses.

Main Results:

  • Transcriptome changes in DM1 patients were significantly associated with increasing disease severity.
  • Key alterations were observed in pathways related to innate and adaptive immunity.
  • These immune-related transcriptomic changes were consistent across both study datasets.

Conclusions:

  • Symptom severity in DM1 is linked to transcriptomic alterations in the immune system.
  • Immune system dysregulation may play a significant role in DM1 pathogenesis and muscle wasting.
  • Further research into the immunological aspects of DM1 is warranted.